LEAFYCOLL LTD

LeafyColl is an AI-native biotechnology company that has developed a molecular farming platform for the scalable, plant-based production of human-identical collagen and other complex structural biomaterials. By utilizing engineered plants as programmable bio-factories, the platform provides a sustainable alternative to traditional animal-derived or microbial fermentation processes, yielding high-purity, bio-identical proteins that are vegan and free from GMOs. The technology integrates AI-driven protein and peptide design with scalable manufacturing processes, enabling the development of functional, high-performance biomaterials designed for industrial and medical-grade precision.

This platform addresses the demand for sustainable, high-quality inputs across sectors including regenerative medicine, advanced wound care, nutraceuticals, and cosmetic formulations. By eliminating reliance on animal and microbial feedstocks, LeafyColl offers a scalable solution for companies looking to integrate premium-grade, human-identical collagen into existing product formulations. The company actively pursues strategic R&D and commercial collaborations to bring its plant-made proteins to global markets, seeking to advance the bio-economy through sustainable, animal-free protein production.